PCA Skin Blemish Control Bar Recalled for High Salicylic Acid Content
Island Kinetics is recalling PCA Skin Blemish Control Bar because the salicylic acid content exceeds the firm's specifications.
What this means for you
Cosmetic or documentation issue. No expected health impact, but the manufacturer is correcting the affected products.
Our severity reasoning: The FDA classified this as a Class III recall, which by definition is unlikely to cause adverse health consequences, fitting the 'Low' severity criteria for minor or theoretical issues.
Plain-English summary
Island Kinetics, Inc. d.b.a. CoValence Laboratories is recalling 2,542 units of PCA Skin Blemish Control Bar, 3.2 oz/90g, Salicylic acid 2% - Acne cleanser. The product is identified by Batch number L041918A, Exp. 04/2021, and Lot # F9518B2. The recall is limited to distribution in Arizona.
The recall was initiated because the salicylic acid content in the product is above the firm's specification. This is classified as a Class III recall by the FDA, indicating that the violation is not likely to cause adverse health consequences.
Consumers who have this product should stop using it and contact the recalling firm for instructions on how to return or dispose of the product.
The recalled product
- Product
- PCA Skin Blemish Control Bar, 3.2 oz/90g, Salicylic acid 2% - Acne cleanser, For external use only, Distributed by PCA Skin, 6210 E. Thomas Rd., Ste. 200, Scottsdale, AZ 85251; UPC 812025010397.
- Category
- Drug — Topical OTC
- Hazard
- Affected units
- 2,542
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Batch number: L041918A
- Exp. 04/2021 Lot # F9518B2
Distribution
Distributed in 1 state:
Related recalls
Same manufacturer · Island Kinetics, Inc. d.b.a. CoValence Laboratories
See all →- ModerateSkin Rehab calming hydrocortisone balm recalled as a subpotent drug
FDA (Drugs) · 2026-04-22
- Moderateglo Skin Beauty Remedy Gel recalled as a subpotent hydrocortisone product
FDA (Drugs) · 2026-04-22
- HighSkin Script blemish spot treatment recalled for failing stability specifications
FDA (Drugs) · 2026-04-22
- ModerateRhonda Allison calming skin gel recalled as a subpotent hydrocortisone product
FDA (Drugs) · 2026-04-22
Same hazard · excessive ingredient
See all →- ModerateEcoLips Sport Lip Balm Recalled for Excessive Avobenzone Concentration
FDA (Drugs) · 2020-06-24
- SevereRed Yeast Rice Supplement Recalled for Excessive Lovastatin Levels
FDA (Drugs) · 2014-05-28